Literature DB >> 2374729

Nucleotide sequence of Clostridium difficile toxin B gene.

L A Barroso1, S Z Wang, C J Phelps, J L Johnson, T D Wilkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2374729      PMCID： PMC331120          DOI： 10.1093/nar/18.13.4004

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  7 in total

1.  Nucleotide sequence of Clostridium difficile toxin A.

Authors:  M Sauerborn; C von Eichel-Streiber
Journal:  Nucleic Acids Res       Date:  1990-03-25       Impact factor: 16.971

2.  Toxin A of Clostridium difficile is a potent cytotoxin.

Authors:  K D Tucker; P E Carrig; T D Wilkins
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

3.  Molecular characterization of the Clostridium difficile toxin A gene.

Authors:  C H Dove; S Z Wang; S B Price; C J Phelps; D M Lyerly; T D Wilkins; J L Johnson
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

4.  Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies.

Authors:  D M Lyerly; C J Phelps; J Toth; T D Wilkins
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

5.  Purification and characterization of toxins A and B of Clostridium difficile.

Authors:  N M Sullivan; S Pellett; T D Wilkins
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

6.  Clinical and laboratory observations in Clostridium difficile colitis.

Authors:  J G Bartlett; N S Taylor; T Chang; J Dzink
Journal:  Am J Clin Nutr       Date:  1980-11       Impact factor: 7.045

7.  Comparison of two toxins produced by Clostridium difficile.

Authors:  N S Taylor; G M Thorne; J G Bartlett
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441
  7 in total
  57 in total

1.  New method to generate enzymatically deficient Clostridium difficile toxin B as an antigen for immunization.

Authors:  H Genth; J Selzer; C Busch; J Dumbach; F Hofmann; K Aktories; I Just
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Cloning of fibA, encoding an immunogenic subunit of the fibril-like surface structure of Peptostreptococcus micros.

Authors:  B H Kremer; J J Bijlsma; J G Kusters; J de Graaff; T J van Steenbergen
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

3.  Role of novel choline binding proteins in virulence of Streptococcus pneumoniae.

Authors:  K K Gosink; E R Mann; C Guglielmo; E I Tuomanen; H R Masure
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  The involvement of macrophage-derived tumour necrosis factor and lipoxygenase products on the neutrophil recruitment induced by Clostridium difficile toxin B.

Authors:  M H Souza; A A Melo-Filho; M F Rocha; D M Lyerly; F Q Cunha; A A Lima; R A Ribeiro
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

5.  Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A.

Authors:  S M Frey; T D Wilkins
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

6.  Monoclonal antibodies specific for Clostridium difficile toxin B and their use in immunoassays.

Authors:  F Müller; C Stiegler; U Hadding
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

7.  Cellular internalisation of bacterial toxins.

Authors:  M Thelestam
Journal:  Cytotechnology       Date:  1991-02       Impact factor: 2.058

8.  Passive immunization of hamsters against disease caused by Clostridium difficile by use of bovine immunoglobulin G concentrate.

Authors:  D M Lyerly; E F Bostwick; S B Binion; T D Wilkins
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 9.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

10.  Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters.

Authors:  J F Torres; D M Lyerly; J E Hill; T P Monath
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.